California Public Employees Retirement System Trims Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

California Public Employees Retirement System cut its holdings in ICU Medical, Inc. (NASDAQ:ICUIGet Rating) by 12.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,939 shares of the medical instruments supplier’s stock after selling 6,081 shares during the quarter. California Public Employees Retirement System owned approximately 0.17% of ICU Medical worth $6,605,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ICUI. American Century Companies Inc. grew its position in shares of ICU Medical by 6.4% in the 1st quarter. American Century Companies Inc. now owns 4,035 shares of the medical instruments supplier’s stock worth $898,000 after buying an additional 243 shares during the period. Group One Trading L.P. grew its position in ICU Medical by 54.6% during the 1st quarter. Group One Trading L.P. now owns 566 shares of the medical instruments supplier’s stock valued at $126,000 after purchasing an additional 200 shares during the last quarter. PNC Financial Services Group Inc. grew its position in ICU Medical by 110.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,766 shares of the medical instruments supplier’s stock valued at $615,000 after purchasing an additional 1,452 shares during the last quarter. Acadian Asset Management LLC grew its position in ICU Medical by 1,098.4% during the 1st quarter. Acadian Asset Management LLC now owns 3,020 shares of the medical instruments supplier’s stock valued at $672,000 after purchasing an additional 2,768 shares during the last quarter. Finally, MetLife Investment Management LLC grew its position in ICU Medical by 33.3% during the 1st quarter. MetLife Investment Management LLC now owns 12,896 shares of the medical instruments supplier’s stock valued at $2,871,000 after purchasing an additional 3,221 shares during the last quarter. 93.88% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, VP Virginia Ruth Sanzone sold 250 shares of the firm’s stock in a transaction dated Tuesday, April 11th. The shares were sold at an average price of $175.00, for a total transaction of $43,750.00. Following the sale, the vice president now owns 4,678 shares of the company’s stock, valued at approximately $818,650. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 7.50% of the company’s stock.

ICU Medical Stock Performance

Shares of NASDAQ ICUI opened at $190.02 on Thursday. The firm’s 50-day moving average price is $174.51 and its 200-day moving average price is $169.09. The company has a quick ratio of 1.01, a current ratio of 2.62 and a debt-to-equity ratio of 0.77. The company has a market cap of $4.57 billion, a PE ratio of -98.97 and a beta of 0.63. ICU Medical, Inc. has a 52-week low of $128.90 and a 52-week high of $212.43.

ICU Medical (NASDAQ:ICUIGet Rating) last announced its quarterly earnings results on Monday, February 27th. The medical instruments supplier reported $1.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.14. The firm had revenue of $578.01 million for the quarter, compared to the consensus estimate of $578.60 million. ICU Medical had a negative net margin of 2.00% and a positive return on equity of 6.42%. As a group, analysts anticipate that ICU Medical, Inc. will post 5.21 EPS for the current year.

Wall Street Analysts Forecast Growth

ICUI has been the topic of several recent analyst reports. 51job reissued a “maintains” rating on shares of ICU Medical in a research report on Tuesday, May 9th. KeyCorp increased their price objective on shares of ICU Medical from $200.00 to $216.00 in a research report on Tuesday, May 9th. Finally, StockNews.com initiated coverage on shares of ICU Medical in a research report on Thursday. They set a “hold” rating on the stock.

ICU Medical Company Profile

(Get Rating)

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.

Featured Articles

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIGet Rating).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.